WASHINGTON — President Trump will be pulling from a wide-ranging grab bag of policy changes for his Friday speech on lowering drug prices, his top health official suggested Thursday.

Health and Human Services Secretary Alex Azar kicked off an appropriations hearing with a list of four policy priorities that included bringing down high list prices, getting the government “a better” deal for the drugs it pays for through programs like Medicare, improving competition, and lowering out-of-pocket costs. As the panel continued, he added that the president will also specifically address the role of pharmacy benefit managers, or PBMs, and ways to “get foreign governments to pay more” for the drugs they use.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy